Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manesh R Patel

Showing results (291-300 of 596) with videos related to

Pageof 60
Sort By:
Circulation. Arrhythmia and Electrophysiology|January 28, 2022
Arrhythmic Burden and the Risk of Cardiovascular Outcomes in Patients With Paroxysmal Atrial Fibrillation and Cardiac Implanted Electronic DevicesDerek S Chew, Zhen Li, Benjamin A Steinberg, et al.
Journal of the American College of Cardiology|September 29, 2018
Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical Revascularization: The EUCLID TrialIris Baumgartner, Lars Norgren, F Gerry R Fowkes, et al.
Journal of Vascular Surgery|January 24, 2024
Psychosocial and socioeconomic factors are most predictive of health status in patients with claudicationLindsey E Scierka, Poghni A Peri-Okonny, Gaelle Romain, et al.
Circulation. Cardiovascular Quality and Outcomes|May 12, 2012
Hospital percutaneous coronary intervention appropriateness and in-hospital procedural outcomes: insights from the NCDRSteven M Bradley, Paul S Chan, John A Spertus, et al.
Circulation. Cardiovascular Quality and Outcomes|May 13, 2017
Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)Ryan Orgel, Daniel Wojdyla, David Huberman, et al.
Journal of the American College of Cardiology|November 23, 2006
Achieving quality in cardiovascular imaging: proceedings from the American College of Cardiology-Duke University Medical Center Think Tank on Quality in Cardiovascular ImagingPamela Douglas, Ami E Iskandrian, Harlan M Krumholz, et al.
Frontiers in Cardiovascular Medicine|August 5, 2022
Understanding Study Drug Discontinuation Through EUCLIDE Hope Weissler, Hillary Mulder, Frank W Rockhold, et al.
JAMA|November 10, 2015
Appropriate Use Criteria for Coronary Revascularization and Trends in Utilization, Patient Selection, and Appropriateness of Percutaneous Coronary InterventionNihar R Desai, Steven M Bradley, Craig S Parzynski, et al.
Lancet (London, England)|April 6, 2022
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 studyJonathan P Piccini, Valeria Caso, Stuart J Connolly, et al.
Circulation|October 18, 2023
Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PADJennifer Rymer, Sonia S Anand, E Sebastian Debus, et al.
Pageof 60

Showing results (291-300 of 596) with videos related to

Sort By:
Pageof 60
Circulation. Arrhythmia and Electrophysiology|January 28, 2022
Arrhythmic Burden and the Risk of Cardiovascular Outcomes in Patients With Paroxysmal Atrial Fibrillation and Cardiac Implanted Electronic DevicesDerek S Chew, Zhen Li, Benjamin A Steinberg, et al.
Journal of the American College of Cardiology|September 29, 2018
Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical Revascularization: The EUCLID TrialIris Baumgartner, Lars Norgren, F Gerry R Fowkes, et al.
Journal of Vascular Surgery|January 24, 2024
Psychosocial and socioeconomic factors are most predictive of health status in patients with claudicationLindsey E Scierka, Poghni A Peri-Okonny, Gaelle Romain, et al.
Circulation. Cardiovascular Quality and Outcomes|May 12, 2012
Hospital percutaneous coronary intervention appropriateness and in-hospital procedural outcomes: insights from the NCDRSteven M Bradley, Paul S Chan, John A Spertus, et al.
Circulation. Cardiovascular Quality and Outcomes|May 13, 2017
Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)Ryan Orgel, Daniel Wojdyla, David Huberman, et al.
Journal of the American College of Cardiology|November 23, 2006
Achieving quality in cardiovascular imaging: proceedings from the American College of Cardiology-Duke University Medical Center Think Tank on Quality in Cardiovascular ImagingPamela Douglas, Ami E Iskandrian, Harlan M Krumholz, et al.
Frontiers in Cardiovascular Medicine|August 5, 2022
Understanding Study Drug Discontinuation Through EUCLIDE Hope Weissler, Hillary Mulder, Frank W Rockhold, et al.
JAMA|November 10, 2015
Appropriate Use Criteria for Coronary Revascularization and Trends in Utilization, Patient Selection, and Appropriateness of Percutaneous Coronary InterventionNihar R Desai, Steven M Bradley, Craig S Parzynski, et al.
Lancet (London, England)|April 6, 2022
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 studyJonathan P Piccini, Valeria Caso, Stuart J Connolly, et al.
Circulation|October 18, 2023
Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PADJennifer Rymer, Sonia S Anand, E Sebastian Debus, et al.
Pageof 60